Does the Form 4 disclose Konrad Dabrowski’s LUCY share ownership after these transactions?

The Form 4 lists the shares transacted and the per-share prices, but the fields for total shares beneficially owned following each transaction are left blank, so post-transaction ownership amounts are not disclosed in this report.

Innovative Eyewear insider sells 13,627 shares

Q: What insider transactions did LUCY report for Konrad Dabrowski on April 2, 2026?

On April 2, 2026, Konrad Dabrowski was granted 20,900 shares of Innovative Eyewear common stock at $0.00 per share and sold 6,692 shares in an open-market or private transaction at $1.0581 per share.

Q: What insider transactions did LUCY report for Konrad Dabrowski on August 19, 2026?

On August 19, 2026, Konrad Dabrowski received a grant of 20,900 shares of common stock at $0.00 per share and sold 6,935 shares at a weighted-average price of $0.6911 per share in open-market or private transactions.

Q: Were Konrad Dabrowski’s LUCY trades made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and the footnotes do not reference a trading plan. The Form 4 therefore does not state that Konrad Dabrowski’s transactions were executed under a Rule 10b5-1 trading arrangement.

Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski. He received grants of 20,900 shares of common stock on April 2, 2026 and August 19, 2026, each at no cost, and sold 6,692 shares on April 2 at $1.0581 per share and 6,935 shares on August 19 at a weighted-average price of $0.6911 per share in open-market or private transactions. Post-transaction holdings were not provided.

Insider Trade Summary

Net Seller: 13,627 shares

Net Sell 4 txns

Insider Dabrowski Konrad

Role Chief AI & Growth Officer

Sold 13,627 shs ($12K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,900	$0.00	$0.00
Sale	Common Stock ^F1	6,935	$0.6911	$5K
Grant/Award	Common Stock	20,900	$0.00	$0.00
Sale	Common Stock	6,692	$1.0581	$7K

Holdings After Transaction: Common Stock — 40,977 shares (Direct)

Footnotes (1)

F1. The price reported in Column 4 is an average price of $0.6911. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Key Figures

Shares granted on April 2, 2026: 20,900 shares of Common Stock Shares sold on April 2, 2026: 6,692 shares of Common Stock Shares granted on August 19, 2026: 20,900 shares of Common Stock +2 more

5 metrics

Shares granted on April 2, 2026 20,900 shares of Common Stock Grant, award, or other acquisition at $0.0000 per share

Shares sold on April 2, 2026 6,692 shares of Common Stock Sale in open market or private transaction at $1.0581 per share

Shares granted on August 19, 2026 20,900 shares of Common Stock Grant, award, or other acquisition at $0.0000 per share

Shares sold on August 19, 2026 6,935 shares of Common Stock Sale at weighted-average price of $0.6911 per share

Total shares sold in reported period 13,627 shares of Common Stock Aggregate of April 2 and August 19, 2026 sales

Key Terms

Grant, award, or other acquisition, Sale in open market or private transaction, weighted-average price

3 terms

Grant, award, or other acquisition regulatory

"transaction code "A" described as Grant, award, or other acquisition"

Sale in open market or private transaction financial

"transaction code "S" described as Sale in open market or private transaction"

weighted-average price financial

"The price reported in Column 4 is an average price of $0.6911"

Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LUCY report for Konrad Dabrowski on April 2, 2026?

On April 2, 2026, Konrad Dabrowski was granted 20,900 shares of Innovative Eyewear common stock at $0.00 per share and sold 6,692 shares in an open-market or private transaction at $1.0581 per share.

What insider transactions did LUCY report for Konrad Dabrowski on August 19, 2026?

On August 19, 2026, Konrad Dabrowski received a grant of 20,900 shares of common stock at $0.00 per share and sold 6,935 shares at a weighted-average price of $0.6911 per share in open-market or private transactions.

How many LUCY shares did Konrad Dabrowski sell according to this Form 4?

Across the reported transactions, Konrad Dabrowski sold a total of 13,627 shares of Innovative Eyewear common stock: 6,692 shares on April 2, 2026 at $1.0581 per share and 6,935 shares on August 19, 2026 at a weighted-average price of $0.6911 per share.

Were Konrad Dabrowski’s LUCY trades made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and the footnotes do not reference a trading plan. The Form 4 therefore does not state that Konrad Dabrowski’s transactions were executed under a Rule 10b5-1 trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/24/2026 - 04:46 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:45 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dabrowski Konrad

(Last)

(First)

(Middle)

C/O INNOVATIVE EYEWEAR INC.

11900 BISCAYNE BLVD., SUITE 630

(Street)

MIAMI

FLORIDA

33181

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief AI & Growth Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/02/2026		A		20,900	A	$0.00	33,704	D
Common Stock	04/02/2026		S		6,692	D	$1.0581	27,012	D
Common Stock	08/19/2026		A		20,900	A	$0.00	47,912	D
Common Stock	08/19/2026		S		6,935	D	$0.6911⁽¹⁾	40,977	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is an average price of $0.6911. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

	/s/ Konrad Dabrowski	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR